GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

By removing the pull of gravity, space has accelerated breakthroughs once thought impossible, reshaping medicine, ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Worried about your child’s nearsightedness? Lakeline Vision in Cedar Park offers advanced treatments to slow myopia ...

The benefits of drug warranties extend beyond risk management. They can also serve as market differentiators in crowded ...

Jay Chhablani, MD, explains how 3D choroidal vessel segmentation transforms ophthalmology, enhancing disease diagnosis and treatment through advanced imaging technology.

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), today announced the Scottish Medicines Consortium (SMC) approval of LYTENAVA™ (bevacizumab gamma) for the treatment of wet age-related macular degeneration ...

Findings presented at the Heidelberg 2025 International Spectralis Symposium — And Beyond suggest detailed structural data could better inform therapeutic targeting and monitoring.

Report Ocean has unveiled an extensive market research report on the Ophthalmic Drugs Market industry, spanning over 150+ countries and drawing insights from more than 100,000 published and upcoming ...